Comparative Analysis of Cervical Cancer Screening Results in 2019 and 2020 in Shihezi Urban Areas, Xinjiang

Comparative Analysis of Cervical Cancer Screening Results in 2019 and 2020 in Shihezi Urban Areas, Xinjiang

Background The results of cervical cancer containment have demonstrated regional differences in China, which may be due to various socioeconomic and cultural developments across regions. Understanding cervical cancer screening results in various regions is of a great significance for developing effe...

Full description

Bibliographic Details
Main Author:	Yu LIU, Yan WEI, Ping YANG
Format:	Article
Language:	zho
Published:	Chinese General Practice Publishing House Co., Ltd 2022-06-01
Series:	Zhongguo quanke yixue
Subjects:	uterine cervical neoplasms\|screening\|human papillomavirus\|colposcopy\|age distribution\|women's health services
Online Access:	https://www.chinagp.net/fileup/1007-9572/PDF/yx2022012007.pdf

Similar Items

Comparative Analysis of Cervical Cancer Screening Results from 2019 to 2021 in Shihezi City, Xinjiang Uyghur Autonomous Region
by: QIAO Hui, WEI Yan, LIU Yu, BAI Rui, YANG Ping
Published: (2024-08-01)

Visual techniques for cervical cancer screening in Colombia
by: Óscar Gamboa, et al.
Published: (2019-03-01)

Microinvasive carcinoma of the uterine cervix in a 14-year-old adolescent: case report and literature review
by: Carla Vitola Gonçalves, et al.

Cervical precancer screening using self-sampling, HPV DNA testing, and mobile colposcopy in a hard-to-reach community in Ghana: a pilot study
by: Kofi Effah, et al.
Published: (2024-11-01)

PRECURSOS LESIONS FOR CERVICAL CANCER AND SOCIODEMOGRAPHIC CHARACTERISTICS OF THE CARRIERS
by: Cássia Caroline Garcia Dalbem Teles, et al.
Published: (2012-09-01)

Colposcopy Value in Young Child-bearing Women: Is New Recommendations Necessary?
by: Fahimeh Sabet, et al.
Published: (2024-12-01)

REPRODUCTIVE ASPECTS ASSOCIATED WITH PRECURSOR LESIONS FOR CERVICAL CANCER
by: Rogério Ferrari, et al.
Published: (2013-05-01)

Risk Profile of High-grade Cervical Lesions and Cervical Cancer Considering the Combination of Cytology, HPV Genotype, and Age among Women Undergoing Colposcopy
by: Júlio César Possati-Resende, et al.
Published: (2023-12-01)

Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program
by: Ali Can Gunes, et al.
Published: (2023-12-01)

Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort studyResearch in context
by: Anna Gottschlich, et al.
Published: (2023-10-01)

Colposcopy at a turning point
by: Kyehyun Nam
Published: (2018-01-01)

Factors associated with high-risk HPV infection and cervical cancer screening methods among rural Uyghur women aged > 30 years in Xinjiang
by: Sulaiya Husaiyin, et al.
Published: (2018-11-01)

Cost analysis of different cervical cancer screening strategies in Mexico
by: Christyn M Beal, et al.
Published: (2014-09-01)

Overcoming Barriers to Cervical Screening Among Pacific Women: A Narrative Review
by: Georgina S. McPherson, et al.
Published: (2019-02-01)

Quality Assessment of Endoscopic Forceps Biopsy Samples under Magnifying Narrow Band Imaging for Histological Diagnosis of Cervical Intraepithelial Neoplasia: A Feasibility Study
by: Kunihisa Uchita, et al.
Published: (2021-02-01)

Risk assessment and triage strategy of cervical cancer primary screening on HPV integration status: 5-year follow-up of a prospective cohort study
by: Xun Tian, et al.
Published: (2024-12-01)

Prevalence of cervical intraepithelial neoplasia grades II/III and cervical cancer in patients with cytological diagnosis of atypical squamous cells when high-grade intraepithelial lesions (ASC-H) cannot be ruled out
by: Andréa Cytryn, et al.

Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+ (CIN2+)
by: Namkha Dorji, et al.
Published: (2022-08-01)

Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged ≥ 69 referred to colposcopy due to an HPV-positive screening test
by: Berit B. Booth, et al.
Published: (2023-05-01)

Understanding the Dynamics of Human Papillomavirus and Diagnostic Discrepancies in Cervical Pathology: A Single Center Experience
by: Milena Zamurovic, et al.
Published: (2023-12-01)

Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review
by: Rita Medeiros, et al.
Published: (2020-03-01)

Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study
by: Yanxia Zhao, et al.
Published: (2021-07-01)

Diagnosis of cervical cancer by a urine test
by: Anna Małgorzata Łopuszyńska, et al.
Published: (2019-08-01)

Diagnosis of cervical cancer by a urine test
by: Anna Małgorzata Łopuszyńska, et al.
Published: (2019-08-01)

Post-conization surveillance in an organized cervical screening program with more than 23,000 years of follow-up
by: Avalon Sundqvist, et al.
Published: (2023-12-01)

Systematic literature review of primary and secondary cervical cancer prevention programs in South America
by: Maria Luziene de Sousa Gomes, et al.
Published: (2023-07-01)

Comparative study of the results from conventional cervico-vaginal oncotic cytology and liquid-based cytology
by: Sueli Aparecida Batista Stabile, et al.

Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics
by: Ivana Di Salvo, et al.
Published: (2023-03-01)

Understanding the role of oncogenic human papillomavirus (HPV) status on adherence behaviors among women with abnormal cervical cytology
by: Catriona Buick, et al.
Published: (2021-01-01)

High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
by: Tae-Wook Kong, et al.
Published: (2020-03-01)

Desempenho do exame colpocitológico com revisão por diferentes observadores e da captura híbrida II no diagnóstico da neoplasia intra-epitelial cervical graus 2 e 3
by: André Luís Ferreira Santos, et al.

Underdiagnosis of cervical intraepithelial neoplasia (CIN) 2 orWorse Lesion inWomenwith a Previous Colposcopy-Guided Biopsy Showing CIN 1
by: Carlos André Scheler de Souza, et al.
Published: (2017-03-01)

Analysis of colposcopy recall cases and influencing factors for women with positive cervical cancer screening in Ordos city
by: Sumeng WANG, et al.
Published: (2024-06-01)

The top hat procedure does not impact the management of women treated by LEEP in cervical cancer screening
by: Juliana Yoko Yoneda, et al.
Published: (2024-06-01)

High frequency of HPV high-risk preventable genotypes in Ecuadorian women with invasive cervical cancer
by: Gustavo David García Muentes, et al.
Published: (2024-12-01)

Using focus groups to plan culturally acceptable primary cervical cancer screening in Grenada, West Indies
by: Calisha Hyacinth-Purcell, et al.
Published: (2023-01-01)

2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia
by: Karla Willows, et al.
Published: (2023-06-01)

DECENA - cervical cancer primary screening program in Vojvodina
by: Rajović Jelka, et al.
Published: (2007-01-01)

HPV infection and cervical cancer
by: Guilherme Lucas de Oliveira Bicca, et al.
Published: (2022-03-01)

A New Brazilian Device for Cervical Cancer Screening: Acceptability and Accuracy of Self-sampling
by: Martina Lichtenfels, et al.
Published: (2023-08-01)